{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cocancérogenèse : Questions médicales les plus fréquentes",
"headline": "Cocancérogenèse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cocancérogenèse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-05",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cocancérogenèse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Carcinogenèse",
"url": "https://questionsmedicales.fr/mesh/D063646",
"about": {
"@type": "MedicalCondition",
"name": "Carcinogenèse",
"code": {
"@type": "MedicalCode",
"code": "D063646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cocancérogenèse",
"alternateName": "Cocarcinogenesis",
"code": {
"@type": "MedicalCode",
"code": "D003043",
"codingSystem": "MeSH"
}
},
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Mental health and visual acuity in patients with age-related macular degeneration.",
"datePublished": "2022-10-02",
"url": "https://questionsmedicales.fr/article/36183081",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-022-02602-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Factors associated with visual acuity improvement with a binocular digital therapeutic for amblyopia.",
"datePublished": "2023-08-21",
"url": "https://questionsmedicales.fr/article/37611818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaapos.2023.06.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of Impairment of Visual Acuity and Severity of Retinopathy in Patients with Diabetes Mellitus.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35940177",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1752-0024"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between dynamic visual acuity and multiple object tracking performance.",
"datePublished": "2022-06-06",
"url": "https://questionsmedicales.fr/article/35668637",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/03010066221104281"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diurnal Variation of Visual Acuity and Refraction in Fuchs Endothelial Corneal Dystrophy.",
"datePublished": "2023-05-08",
"url": "https://questionsmedicales.fr/article/37157119",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ICO.0000000000003291"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
},
{
"@type": "ListItem",
"position": 5,
"name": "Carcinogenèse",
"item": "https://questionsmedicales.fr/mesh/D063646"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cocancérogenèse",
"item": "https://questionsmedicales.fr/mesh/D003043"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cocancérogenèse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cocancérogenèse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cocancérogenèse",
"description": "Comment diagnostiquer la cocancérogenèse ?\nQuels tests sont utilisés pour évaluer la cocancérogenèse ?\nQuels signes cliniques peuvent indiquer une cocancérogenèse ?\nLa cocancérogenèse est-elle détectable par imagerie ?\nQuel rôle jouent les antécédents médicaux dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Visual+Acuity&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cocancérogenèse",
"description": "Quels sont les symptômes associés à la cocancérogenèse ?\nLa cocancérogenèse provoque-t-elle des douleurs ?\nY a-t-il des symptômes spécifiques selon le type de cancer ?\nLes symptômes de cocancérogenèse sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Visual+Acuity&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cocancérogenèse",
"description": "Comment prévenir la cocancérogenèse ?\nLe dépistage précoce aide-t-il à prévenir la cocancérogenèse ?\nQuels aliments aident à prévenir la cocancérogenèse ?\nL'exercice physique joue-t-il un rôle dans la prévention ?\nLes vaccinations peuvent-elles prévenir la cocancérogenèse ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Visual+Acuity&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cocancérogenèse",
"description": "Quels traitements sont disponibles pour la cocancérogenèse ?\nLa prévention est-elle un traitement pour la cocancérogenèse ?\nLes traitements varient-ils selon le type de cancer ?\nLa thérapie ciblée est-elle efficace contre la cocancérogenèse ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Visual+Acuity&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cocancérogenèse",
"description": "Quelles complications peuvent survenir avec la cocancérogenèse ?\nLa cocancérogenèse peut-elle entraîner des complications respiratoires ?\nY a-t-il des complications liées aux traitements ?\nComment gérer les complications de la cocancérogenèse ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Visual+Acuity&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cocancérogenèse",
"description": "Quels sont les principaux facteurs de risque de cocancérogenèse ?\nL'hérédité joue-t-elle un rôle dans la cocancérogenèse ?\nLes infections peuvent-elles être un facteur de risque ?\nLe mode de vie influence-t-il le risque de cocancérogenèse ?\nL'exposition à la radiation est-elle un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Visual+Acuity&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la cocancérogenèse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la cocancérogenèse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage, biopsies et analyses génétiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques peuvent indiquer une cocancérogenèse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des lésions cutanées ou des anomalies cellulaires peuvent apparaître."
}
},
{
"@type": "Question",
"name": "La cocancérogenèse est-elle détectable par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à visualiser des tumeurs, mais pas la cocancérogenèse elle-même."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les antécédents médicaux dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'exposition à des agents carcinogènes sont cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes associés à la cocancérogenèse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure fatigue, douleurs inexpliquées et changements de peau."
}
},
{
"@type": "Question",
"name": "La cocancérogenèse provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de tumeurs ou d'inflammation associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques selon le type de cancer ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes varient selon le type de cancer lié à la cocancérogenèse."
}
},
{
"@type": "Question",
"name": "Les symptômes de cocancérogenèse sont-ils toujours visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains symptômes peuvent être asymptomatiques et nécessitent un dépistage."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec le temps si la cocancérogenèse progresse."
}
},
{
"@type": "Question",
"name": "Comment prévenir la cocancérogenèse ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les agents carcinogènes et adopter un mode de vie sain sont essentiels."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il à prévenir la cocancérogenèse ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce peut détecter des anomalies avant qu'elles ne deviennent cancéreuses."
}
},
{
"@type": "Question",
"name": "Quels aliments aident à prévenir la cocancérogenèse ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits, légumes et antioxydants peut réduire les risques."
}
},
{
"@type": "Question",
"name": "L'exercice physique joue-t-il un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut diminuer le risque de développer des cancers."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir la cocancérogenèse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la cocancérogenèse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La prévention est-elle un traitement pour la cocancérogenèse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les agents carcinogènes est une forme de traitement préventif."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de cancer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés en fonction du type de cancer et de son stade."
}
},
{
"@type": "Question",
"name": "La thérapie ciblée est-elle efficace contre la cocancérogenèse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie ciblée peut être efficace pour certains cancers liés à la cocancérogenèse."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue et immunosuppression."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la cocancérogenèse ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la progression du cancer et la métastase vers d'autres organes."
}
},
{
"@type": "Question",
"name": "La cocancérogenèse peut-elle entraîner des complications respiratoires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cancers peuvent affecter la fonction pulmonaire et causer des complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées aux traitements ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des complications comme l'infection ou l'anémie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications de la cocancérogenèse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi médical régulier et des traitements symptomatiques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement altérer la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de cocancérogenèse ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'alcool."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans la cocancérogenèse ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de cocancérogenèse."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme le HPV, sont des facteurs de risque connus pour le cancer."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de cocancérogenèse ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à la radiation est-elle un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des radiations ionisantes est un facteur de risque pour certains cancers."
}
}
]
}
]
}
Visual acuity (VA) loss has been associated with depression in patients with age-related macular degeneration (AMD). However, previous studies did not incorporate subgroups of AMD when correlating VA ...
AMD patients classified by multi-modal imaging were recruited into an AMD registry. Habitual VA was obtained by ophthalmic technicians using the Snellen VA at distance. At enrollment, patients complet...
Eight hundred seventy-five patients were included in the study. Patients with bilateral geographic atrophy (GA) or bilateral GA and neovascular (NV) AMD scored lowest on the mental health subscales wi...
There is a significant association between mental health questionnaire scores and AMD classification, as well as VA in both the better and worse-seeing eyes in patients with AMD. It is important for c...
We combined data from 121 amblyopic children enrolled in two prospective open-label pilot studies and a randomized trial of a binocular digital therapeutic to identify factors associated with positive...
No information exists on the frequency of visual impairment in people with diabetes mellitus (DM) in Germany. In this study, the prevalence of vision impairment in those individuals was investigated....
We retrospectively analyzed a cohort of 295 people (14221 consultations) at a university outpatient clinic with any type of DM and an available ETDRS-Score and visual acuity. The primary outcome was t...
The prevalence of visual impairment in participants with DM was 11.2%; among these individuals, 81.8% had no or non-proliferative retinopathy. In the DM2 subgroup, 81.5% (n=22) of the visually impaire...
The prevalence of impaired vision in people with diabetes in our cohort was 11.2%,<20% of visual impairment in people with diabetes is caused by diabetic retinopathy, and 69.7% of participants with vi...
We assessed the association between measures of dynamic visual acuity and a multiple object tracking task in physically active young adults. Ninety-four young adults performed the dynamic visual acuit...
Patients with advanced Fuchs endothelial corneal dystrophy frequently report poor vision in the morning, which improves as the day progresses. This study quantified the amount of variation in near and...
This was a prospective cohort study. Best-corrected distance visual acuity and near visual acuity were tested in participants with clinically advanced Fuchs dystrophy and in controls with healthy corn...
In Fuchs dystrophy, the mean distance visual acuity was worse by -3 letters (95% confidence interval, -4 to -1) directly after eye opening in the morning compared with late afternoon. No such differen...
Distance and near visual acuity and refraction changes over the course of the day in patients with advanced Fuchs dystrophy. Although small changes in refraction may not usually require a second set o...
Monitoring dynamic changes in near vision is important for early detection of presbyopia. This study assessed the accuracy and reliability of a new smartphone-based application, the Smart Vision Check...
Smaller pupil size under binocular conditions could justify partially the improvement of visual performance when compared to monocular conditions. The purpose of this study was to assess the binocular...
Fifteen young subjects were recruited in this crossover study. Light disturbance index (LDI) was evaluated with the light disturbance analyzer and low (LCDVA) and high (HCDVA) contrast visual acuity w...
Our results showed poorer visual performance in monocular than the binocular condition. An increasing deterioration was observed with the level of spherical defocus. Positive binocular summation for v...
Binocular summation was observed under different conditions of spherical and cylindrical optical degradation of the image quality when the pupil size was fully controlled. This suggests that a neural ...
High-contrast visual acuity is disproportionately poor in patients with accommodative spasm subtype of near reflex (SNR-A), relative to uncorrected refractive errors of equivalent magnitude. This exag...
To determine how combinations of pseudomyopic refraction and its temporal variations in SNR-A impact high-contrast visual acuity by inducing these patterns in healthy cyclopleged adults, relative to t...
Refractive profiles of 15 patients with SNR-A were obtained from a previous study, averaged, and induced before the right eye of 14 cyclopleged adults (mean ±1 SD age: 22.7 ± 2.6 yrs) by feeding the p...
The induced refractive fluctuations ranged from -0.80 to -1.75D, around a mean pseudomyopia of -1.20D. Visual acuity deterioration was maximum for the combination of pseudomyopia and temporal fluctuat...
Combination of induced pseudomyopia and temporal fluctuations in refraction produces an additive loss of visual acuity and task precision, relative to baseline and each factor considered separately....
Cataract and neovascular age-related macular degeneration (nAMD) often co-exist and both contribute to impaired vision. It has been debated whether cataract surgery can increase nAMD activity. The pur...
Data was obtained from the Swedish Macular Register, the Swedish National Cataract Register, optical coherence tomography (OCT) images and patient charts. All eyes were treated at the Department of Op...
In total, 156 patients (168 eyes) were included. The mean age at cataract surgery was 82 (standard deviation, SD 6) years. Both distance and near visual acuity improved after surgery. Distance visual ...
Cataract surgery improved visual acuity in patients with on-going treatment for nAMD and did not affect anti-VEGF treatment intensity. Macular morphology remained unchanged. The slight increase in int...
In this study, we investigated a convolutional neural network (CNN)-based framework for the estimation of the best-corrected visual acuity (BCVA) from fundus images. First, we collected 53,318 fundus ...